EUVIMEDEUVIMED entdecken
Crossref

The changing landscape of small cell lung cancer

Giordano Fabricio Cittolin-Santos iD, Brendan Knapp iD, Bharath Ganesh, Feng Gao, Saiama Waqar, Thomas Eldridge Stinchcombe iD, Ramaswamy Govindan, Daniel Morgensztern iD

Cancer · 15.07.2024 · 130 (14) · 2453-2461

DOI: 10.1002/cncr.35281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 12.03.2024. Verfasst von Giordano Fabricio Cittolin-Santos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms, SEER Program. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Small‐cell lung cancer (SCLC) is characterized by rapid proliferation and early dissemination. The objective of this study was to examine the demographic trends and outcomes in SCLC.

Methods

The authors queried the National Cancer Institute's Surveillance, Epidemiology, and End Results database to assess the trends in incidence, demographics, staging, and survival for SCLC from 1975 to 2019. Trends were determined using joinpoint analysis according to the year of diagnosis.

Results

Among the 530,198 patients with lung cancer, there were 73,362 (13.8%) with SCLC. The incidence per 100,000 population peaked at 15.3 in 1986 followed by a decline to 6.5 in 2019. The percentage of SCLC among all lung tumors increased from 13.3% in 1975 to a peak of 17.5% in 1986, declining to 11.1% by 2019. There was an increased median age at diagnosis from 63 to 69 years and an increased percentage of women from 31.4% to 51.2%. The percentage of stage IV increased from 58.6% in 1988 to 70.8% in 2010, without further increase. The most common sites of metastasis at diagnosis were mediastinal lymph nodes (75.3%) liver (31.6%), bone (23.7%), and brain (16.4%). The 1‐year and 5‐year overall survival rate increased from 23% and 3.6%, respectively, in 1975–1979 to 30.8% and 6.8%, respectively, in 2010–2019.

Conclusions

The incidence of SCLC peaked in 1988 followed by a gradual decline. Other notable changes include increased median age at diagnosis, the percentage of women, and the percentage of stage IV at diagnosis. The improvement in 5‐year overall survival has been statistically significant but clinically modest.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsSEER ProgramHumansFemaleMaleMiddle AgedAgedIncidenceUnited StatesNeoplasm StagingAdultAged, 80 and overSurvival Rate

Stichwörter der Autor:innen

Surveillance, Epidemiology, and End Results (SEER)incidencejoinpoint analysisoverall survivalsmall cell lung cancersmokingtobacco

Autor:innen und Institutionen

  • Division of Oncology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
  • Departments of Medicine and Neurosurgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Division of Public Health Science, Department of Surgery, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
  • Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA.

ORCID-Profile: Giordano Fabricio Cittolin-Santos, Brendan Knapp, Thomas Eldridge Stinchcombe, Daniel Morgensztern

Zitieren

APA

Cittolin-Santos, G. F., Knapp, B., Ganesh, B., Gao, F., Waqar, S., Stinchcombe, T. E., Govindan, R., & Morgensztern, D. (2024). The changing landscape of small cell lung cancer. Cancer, 130(14), 2453-2461. https://doi.org/10.1002/cncr.35281

Vancouver

Cittolin-Santos GF, Knapp B, Ganesh B, Gao F, Waqar S, Stinchcombe TE, et al. The changing landscape of small cell lung cancer. Cancer. 2024;130(14):2453-2461. doi:10.1002/cncr.35281

BibTeX
@article{CittolinSantos2024,
  author = {Cittolin-Santos, Giordano Fabricio and Knapp, Brendan and Ganesh, Bharath and Gao, Feng and Waqar, Saiama and Stinchcombe, Thomas Eldridge and Govindan, Ramaswamy and Morgensztern, Daniel},
  title = {The changing landscape of small cell lung cancer},
  journal = {Cancer},
  year = {2024},
  volume = {130},
  number = {14},
  pages = {2453--2461},
  doi = {10.1002/cncr.35281}
}
Kostenlos starten →